Recommendations for estrogen and progestin replacement in the climacteric and postmenopause. European Progestin Club.
The diversity of function that sex steroids have proven to have in the female body, gives them a position of central importance in gynaecology. Scientific research demonstrates not only the well known genital functions of sexual steroids, furthermore, various extragenital organs are influenced and modulated by ovarian hormones. Therefore, the general benefit of HRT for the female organism becomes clearer and the clinical management of menopause is developing to a broad new discipline, the gender specific medicine. In clinical practise, phytosteroids are claimed by the patient and therefore, also of high interest for the scientific research. Also, tissue specificity of the endocrine treatment and the biological relevance of different steroid receptors of HRT are discussed, leading to the development of new HrT preparations. Individualisation, the tailoring of HRT, according to the patients needs, and low dose steroids management, will also become an important aspect in the recommendations for estrogen and progestin replacement therapy.
Huber
J C
JC
Klinik der Frauenheilkunde der Universität, Währinger Gürtel, Vienna, Austria.
Campagnoli
C
C
Druckmann
R
R
Ebert
C
C
Pasqualini
J R
JR
Ruby
J
J
Schweppe
K W
KW
Schindler
A E
AE
Thijssen
J H
JH
D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause; D017698:Postmenopause; D017410:Practice Guidelines as Topic; D011372:Progestins / Q000627:therapeutic use*
D004967:Estrogens; D011372:Progestins